跳至主要内容
临床试验/NCT04493073
NCT04493073Unknown早期 1 期

Comparison of Conjunctival Vascularity Changes Using Optical Coherence Tomography Angiography After Trabeculectomy With Mitomycin and Ologen Implants

Asmaa Ahmed Ali Youssif0 个研究点目标入组 100 人开始时间: 2020年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
发起方
入组人数
100
主要终点
conjunctival vascularity changes

研究概览

简要总结

  • Reduce the trauma and the time taken for patient rehabilitation.
  • The prevailing trend is to perform a mitomycin- C (MMC)-augmented trabeculectomy and trabeculectomy with ologen implants in a trial to decrease bleb failure as a common post- trabeculectomy complication.
  • Is to develop a measurement protocol by OCT-A imaging and characterization of the bleb vascularity changes in glaucoma patients before and after surgery.

详细描述

The main purpose of this project is to compare bleb vascularity changes using optical coherence tomography (OCT-A) between mitomycin- C (MMC)-augmented trabeculectomy and develop trabeculectomy with ologen implants to determine whether bleb vascularity measurements during preoperative and early postoperative periode could act as surrogate parameters to predict surgical outcomes.

Glaucoma often existent in the elderly population. Measuremets of bleb vascularity beginning to become an essential part of the glaucoma specialist's clinical and operative took. As investigators continue to collect data both clinically and in the laboratory, these various imaging modalities will shepherd surgeons into a more precise and predicable era of glaucoma surgeries.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients older than 18 years of age with primary or secondary open-angle glaucoma.
  • Primary OAG (POAG) diagnosed on the basis of IOP measurements more than 21 mmHg, open angle on gonioscopy (Grade 3 or 4 on Schaffer grading system for angle width), glaucomatous visual field defects consistent with glaucomatous optic disc changes.
  • PNAG was diagnosed by the presence of narrow or occludable angle on gonioscopy (Grade 2, or 1 on Schaffer grading system for angle width in at least 180° of the total circumference of the angle in primary position without indentation), glaucomatous optic disc changes, visual field defects and IOP more than 21 mmHg

排除标准

  • pregnant or lactating female.
  • previous intraocular surgery
  • one-eyed patients.
  • previous ocular trauma.
  • uveitis-induced glaucoma, neovascular glaucoma, aphakic/pseudophakic glaucoma
  • systemic connective tissue disease and missing more than 3 follow-up visits.
  • Trabeculectomy augmented by either MMC or Ologen implant was indicated to study subjects if they had uncontrolled IOP under maximum antiglaucoma medications (3 antiglaucoma drugs) or due to poor socioeconomic status.

研究组 & 干预措施

Trabectulectomy with mitomycin

Active Comparator

Mitomycin-C Kyowa® (Biochem Pharmaceutical Industries, India) 10 mg vial 2 mg/ml concentration

干预措施: Trabectulectomy (Procedure)

Trabectulectomy with mitomycin

Active Comparator

Mitomycin-C Kyowa® (Biochem Pharmaceutical Industries, India) 10 mg vial 2 mg/ml concentration

干预措施: Mitomycin (Drug)

Trabectulectomy with mitomycin

Active Comparator

Mitomycin-C Kyowa® (Biochem Pharmaceutical Industries, India) 10 mg vial 2 mg/ml concentration

干预措施: Mitomycin-C Kyowa® (Device)

Trabectulectomy with Ologen implants

Active Comparator

Ologen Collagen Implant (Aeon Astron Europe, Netherlands) - three-dimensional collagen- GAG implant >90% lyophilized porcine atelocollagen and <10% lyophilized porcine GAG 12 mm in diameter with 1 mm of thickness and 6 mm in diameter with 2 mm of thickness

干预措施: Trabectulectomy (Procedure)

Trabectulectomy with Ologen implants

Active Comparator

Ologen Collagen Implant (Aeon Astron Europe, Netherlands) - three-dimensional collagen- GAG implant >90% lyophilized porcine atelocollagen and <10% lyophilized porcine GAG 12 mm in diameter with 1 mm of thickness and 6 mm in diameter with 2 mm of thickness

干预措施: Ologen Collagen Implant (Device)

结局指标

主要结局

conjunctival vascularity changes

时间窗: 1 year

conjunctival vascularity changes using OCTA

次要结局

未报告次要终点

研究者

发起方
Asmaa Ahmed Ali Youssif
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Asmaa Ahmed Ali Youssif

doctor

Assiut University

相似试验

Conjunctival Vascularity Changes Usnig OCTA After... | 临床试验